Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)
NCT02943538 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-01-18
Summary
Pragmatic clinical trial, randomized, controlled parallel, 3 group (group technology platform, call group and control group), developed in the monograph Reference Unit of Inflammatory Bowel Disease Valencia (single-center).
Conditions
- Crohn's Disease
- Colitis, Ulcerative
Interventions
- DEVICE
-
Telemedicine
Monitoring and control is performed through telematics platform integrated management of chronic NOMHAD, configurated to respond the patients specific needs.
- DEVICE
-
Telephone
A telephone control of their state and evolution will be made through the nursing staff of the unit.
- OTHER
-
Conventional care
Conventional care provided in the unit to patients with IBD -high moderate complexity.
Sponsors & Collaborators
-
Instituto de Investigacion Sanitaria La Fe
lead OTHER
Principal Investigators
-
Marian Aguas · Instituto de Investigación Sanitaria La Fe
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
More Related Trials
-
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
NCT06231264 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
NCT06954311 ·Status: RECRUITING
-
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease
NCT01183403 ·Status: COMPLETED
-
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
NCT03710486 ·Status: COMPLETED
-
Laquinimod Phase IIa Study in Active Crohn's Disease
NCT00737932 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
NCT07250815 ·Status: COMPLETED
-
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT03138655 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
NCT05428345 ·Status: RECRUITING
-
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis
NCT02883452 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis
NCT02291523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Thermography in Surveillance of Ulcerative Colitis
NCT02149043 ·Status: COMPLETED
-
Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care
NCT01296841 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2011).
NCT02392221 ·Status: COMPLETED
-
Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA
NCT06856135 ·Status: AVAILABLE
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
NCT01369342 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
NCT02425111 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
NCT01369329 ·Status: COMPLETED ·Phase: PHASE3
-
Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Crohn's Disease
NCT06933264 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
NCT02921555 ·Status: TERMINATED ·Phase: PHASE4
-
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
NCT00269841 ·Status: COMPLETED ·Phase: PHASE3
-
Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease
NCT02319798 ·Status: COMPLETED ·Phase: NA
-
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis
NCT03679546 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life
NCT03378388 ·Status: TERMINATED
-
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT03196427 ·Status: COMPLETED ·Phase: PHASE2